Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
| Image |  |
|---|---|
| Description | scientific article published on 31 August 2020 |
| Author/s |
author: Toshiki Masuishi Takao Takahashi |
| Publication date | August 31, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |